VALERIS LAUNCHES WITH A FULLY INTEGRATED VISION FOR LIFE SCIENCES COMPANIES

New brand name and identity marks completion of the merger of industry leaders Mercalis and PharmaCord

MORRISVILLE, N.C. and JEFFERSONVILLE, Ind., May 27, 2025 /PRNewswire/ -- Mercalis, an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain, and PharmaCord, a leading provider of patient services for the biopharmaceutical industry, today announced the completion of their merger and their concurrent rebranding of the combined company as Valeris. The merger, originally announced in March 2025, creates a combined platform – backed by global investment firm Permira and Odyssey Investment Partners – that redefines how life sciences companies bring innovative therapies to life and creates the biopharmaceutical industry's leading provider of patient support services. Valeris was purpose-built to rise to the challenges of today's increasingly complex healthcare landscape – and lead into the future.

By uniting capabilities that deliver value throughout the commercialization process – data and strategic insights, patient support services, and healthcare provider engagement tools, Valeris represents a bold commitment to a better patient experience by streamlining access, reducing barriers, and supporting adherence.

"To remain effective and relevant, patient support must evolve, shifting from commoditized models to dynamic, data-driven ecosystems designed for long-term value," said Rob Truckenmiller, Chief Executive Officer of Valeris. "With deep expertise in patient support services and market access, an advanced technology infrastructure, and an experienced commercial team, Valeris is fully committed to power life sciences companies and enhance patient lives."

"Valeris is the product of over 33 years of industry expertise," added Scott Dulitz, President of Valeris.  "This brand marks more than a name change – it signals our commitment to leading progress in healthcare. By bringing together proven capabilities under one purpose-driven organization, we're making the path from diagnosis to patient outcomes more seamless, more supported, and more human. We're built to help our partners thrive in today's complexity – and shape what comes next."

About Valeris
Valeris is a fully integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company works on behalf of life sciences companies to improve the patient experience so that patients can access and adhere to critical medications. Backed by proven industry expertise, a deep commitment to patient care, the latest technology, and exceptionally talented team members, Valeris provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Valeris provides commercialization solutions to more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in Morrisville, North Carolina and Jeffersonville, Indiana. To learn more about Valeris, please visit www.valeris.com.

Media Contact:
Landy Townsend,
VP, Marketing & Communications,
Valeris
[email protected] 

SOURCE Mercalis